News di Eurofins Italia
BioPharma News - 7a edizione
Eurofins presenta la nuova edizione della newsletter BioPharma NEWS. Gli articoli contenuti in questa edizione sono relativi ai servizi offerti dal gruppo Eurofins nell'ambito di: Argon Therapeutics earns global regulatory approval with Eurofins LancasterLaboratories' rapid mycoplasma Milliprobe assay; UV-C inactivation: a new viral inactivation method for biopharmaceuticals; Which Antimicrobial Efficacy Study is best for your product; How will the new EU 528/2013 regulation affect biocidal product testing; Toxicological evaluation: the bridge between extractables and leachables; Mind the gap between ISO 10993 and submission to FDA.
Previous newsBioPharma news - 6a edizionePharma News - 5a edizioneAnnuncio acquisizone CTP LaboratoriesPharma News - 4a edizioneEurofins completes 2012 Laboratory Expansion PlanInternational Leaders Eurofins and MWH Global Complete Strategic Sale and Services Agreement for MWH LaboratoriesPharma News - 3a edizioneEurofins celebrates 25 years of laboratory excellenceEurofins strengthens Asia Pacific footprint with the acquisition of New Zealand Laboratory ServicesPharma News -2° edizioneEurofins Biolab al Simposio AFI 2012Eurofins reinforces leadership in the Brazilian testing marketEurofins reinforces leadership in the Benelux testing marketEurofins raises dividends and objectives for 2012Eurofins Biolab partecipa alla Fiera Expomed 2012Eurofins Enters Into an Agreement to Acquire QTA and a Supply Agreement with BASFPharma News - 1° edizioneEurofins leverages worldwide leadership to benefit the Food & Feed Industry with the launch of its Webinar ServicesEurofins achieved its aggressive objectives with strong earnings growth in 2011Eurofins Doubles Net Profit in the First Nine Months of 2011Eurofins announces successful closing of the transaction for a majority stake in IPL SED Nord and IPL InvestEurofins raises its sales and profit outlook for 2011 at its Annual Investor DayEurofins signs definitive agreement to acquire majority stakes in Institut Pasteur de Lille subsidiaries, IPL SED Nord and IPL InvestNantes Laboratory InaugurationEurofins highlights Asian presence to respond to calls for greater food safety levels in the regionStrong Growth and Operating Leverage Trebles Eurofins’ Net Profit in H1 2011Eurofins concludes loan issuance to further optimize balance sheetEurofins signs an exclusive agreement with the Fondation Institut Pasteur de Lille towards a partnership in the environmental testing fieldEurofins opens state-of-the-art high throughput laboratory for Radioactive Material Analysis in JapanEurofins at the forefront of Full Genome Sequencing for industryEurofins doubles dividends to shareholdersStrong Q1 topline growth provides solid start to 2011Allergen multi-screening in a single analysisEurofins announces successful closing of Lancaster acquisitionEurofins generates strong Free Cash Flows in 2010Eurofins signs agreement to acquire Lancaster Laboratories, IncEurofins reaffirms its mid-term objectivesPharma NEWSDirettiva Attrezzature di lavoroAccreditamento CBTL (Certification Body Test Laboratory)iscrizione sostanzecontrolli micro